公司是高新技术企业、国家级专精特新"小巨人"企业。同时，公司先后荣获了国家技术发明奖二等奖、 中国国际工业博览会银奖、中国制冷学会科学技术进步一等奖、中国医疗器械行业十大科技创新品牌、 2020 中国设计红星原创奖、美国 UL 能效之星、安徽省科学技术奖二等奖、安徽省企业技 术中心、安 徽省工业设计中心、安徽省专利优秀奖、安徽省工业精品、合肥市科学技术奖、合肥市企业技术中心、 全国工人先锋号、合肥市工人先锋号和合肥十佳设计创新型企业、安徽省工人先锋号等国家、省、市级 别的各项荣誉称号。 2025年上半年，公司始终坚持"以技术为基础，以产品为载体，以市场为导向，以客户为中心"的经 营 理念，在生物医疗领域核心制冷技术上持续获得突破，助力生命科学仪器技术水平提升，加快国产替代 步伐。公司推行"聚焦样本生态，纵向深入样本库全链条；立足生命科学，横向拓展实验室通用设备领 域"产品协同策略，以"为用户创造价值"为导向，专注用户、成就客户，不断巩固市场竞争 地位，完善 国内外市场布局，向成为全球领先的生命科学领域定制化系统解决方案服务商的目标不断奋进。 业绩方面，2025年前三季度，公司实现营业收入2.24亿元，同比增长 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Views - The report highlights the competitive advantage of Qian Dama through its "community small store + daily clearance mechanism + warehouse and cold chain" model, which enhances supply stability and operational efficiency [3][24][35] - The report emphasizes the importance of emotional consumption themes and identifies high-quality companies in high-growth sectors, recommending specific companies across various segments [6][37] Summary by Sections Industry Overview - The retail and social service indices reported a decline of 1.47% and an increase of 1.53% respectively during the week of January 12-16, 2026 [5][13] - The internet e-commerce sector showed the highest growth, with a year-to-date increase of 11.18% [16][19] Company Highlights - Qian Dama has submitted its IPO application to the Hong Kong Stock Exchange, focusing on fresh food retail in the South China market, with a GMV of 9.8 billion yuan in 2024, significantly outperforming its competitors [24][25] - The company operates 2,983 stores, with 2,898 being franchise stores, contributing over 90% of its revenue [25][31] - The report recommends several companies based on their performance and market positioning, including: - Chaohongji, expected to achieve a net profit of 436-533 million yuan in 2025, driven by brand upgrades and channel expansion [39][43] - Meilitiantian Medical Health, projected to see a revenue increase of 28.2% in FY2025H1 [39] - Zhou Dafu, focusing on product structure optimization and store upgrades [39] Investment Themes - Investment Theme 1: Focus on high-end gold and fashion jewelry brands, recommending Chaohongji and Laopu Gold [6][37] - Investment Theme 2: Emphasize retail companies adapting to trends and AI-enabled cross-border e-commerce leaders, recommending Yonghui Supermarket and Aiyingshi [6][37] - Investment Theme 3: Highlight domestic beauty brands that meet emotional value and safety innovation, recommending Maogeping and Pola [6][37] - Investment Theme 4: Focus on differentiated medical beauty product manufacturers and leading medical beauty institutions, recommending Meilitiantian Medical Health and Aimeike [6][37]

Group 1 - The company Zhongke Meiling has completed the registration of industrial and commercial changes and the filing of its articles of association, obtaining a new business license [2] - The legal representative of the company has changed from "Wu Dinggang" to "Fang Rongxin" [2] - Other industrial and commercial registration items recorded in the business license have not changed [2]

Core Viewpoint - Zhongke Meiling announced a credit guarantee plan for its wholly-owned subsidiaries to address funding gaps and support their development [2] Group 1: Credit Guarantee Details - The company plans to provide a total credit guarantee of up to 30 million yuan for its subsidiaries Anhui Tuoxing Technology Co., Ltd. and Anhui Ling'an Medical Equipment Co., Ltd. [2] - The guarantee for Tuoxing Technology is capped at 10 million yuan, while the guarantee for Ling'an Medical is capped at 20 million yuan [2] - The guarantee period for both subsidiaries is set for one year, and they will provide full net asset collateral to Zhongke Meiling [2]

Core Viewpoint - Zhongke Meiling announced the approval of an investment plan using idle funds for financial management, with a maximum investment of 200 million RMB [2] Group 1: Investment Plan - The company and its subsidiaries plan to use up to 200 million RMB of idle funds for bank financial product investments [2] - The investment period is valid for one year from the date of approval at the second extraordinary general meeting of shareholders in 2024 [2] Group 2: Current Financial Status - As of now, the company has 150 million RMB in outstanding financial products, which includes the newly purchased products [2] - This amount represents 24.52% of the company's audited net assets for the year 2024 [2]

Core Viewpoint - Zhongke Meiling announced that its major shareholder, Zhongke Xianxing (Beijing) Asset Management Co., Ltd., plans to reduce its holdings by up to 1.93 million shares, not exceeding 2% of total shares, due to personal funding needs [1] Summary by Category - **Shareholder Actions** - The major shareholder intends to reduce its stake through centralized bidding or block trading within three months after the announcement [1] - The shares to be sold were acquired before the company went public [1] - **Financial Implications** - The reduction in shares is driven by the shareholder's personal funding requirements [1]

Group 1 - On November 6, a total of 8 companies had their restricted shares unlocked, with a total unlock volume of 69.52 million shares, equating to a market value of 1.892 billion yuan based on the latest closing price [1] - Nanjing Securities, Zhongke Meiling, and Transsion Holdings had the highest unlock volumes, with 26.57 million shares, 19.50 million shares, and 10.83 million shares respectively [1] - In terms of unlock market value, Transsion Holdings, Zhongke Meiling, and Nanjing Securities led with market values of 760 million yuan, 415 million yuan, and 226 million yuan respectively [1] Group 2 - Zhongke Meiling, Dike Co., and Transsion Holdings had the highest unlock ratios, with ratios of 20.16%, 2.42%, and 0.94% respectively [1]

证券代码：835892 证券简称：中科美菱 公告编号：2025-113 中科美菱低温科技股份有限公司 关于召开 2025 年第二次临时股东会通知公告（提供网络投票） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开基本情况 （一）股东会届次 本次会议为 2025 年第二次临时股东会。 （二）召集人 2、网络投票起止时间：2025 年 10 月 14 日 15:00—2025 年 10 月 15 日 15:00。 登记在册的股东可通过中国证券登记结算有限责任公司（以下简称"中国结 算"）持有人大会网络投票系统对有关议案进行投票表决，为有利于投票意见的 顺利提交，请拟参加网络投票的投资者在上述时间内及早登录中国结算网上营业 厅（网址：inv.chinaclear.cn）或关注中国结算官方微信公众号（"中国结算营 本次股东会的召集人为董事会。 （三）会议召开的合法合规性 本次股东会的召集、召开、议案审议所履行的程序符合《公司法》等有关 法律、法规及《公司章程》的规定。 （四）会议召开方式 本次会议 ...

一、会议召开和出席情况 证券代码：835892 证券简称：中科美菱 公告编号：2025-112 中科美菱低温科技股份有限公司 第四届董事会第五次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 （一）会议召开情况 1.会议召开时间：2025 年 9 月 29 日 2.会议召开地点：公司会议室 3.会议召开方式：通讯方式 4.发出董事会会议通知的时间和方式：2025 年 9 月 26 日以电子邮件方式发 出 5.会议主持人：董事长吴定刚先生 6.会议列席人员：公司监事会成员、董事会秘书及其他高级管理人员 7.召开情况合法、合规、合章程性说明： 本次会议的召集、召开、议案审议程序等符合有关法律、行政法规、部门规 章、规范性文件和《公司章程》的有关规定。 （二）会议出席情况 会议应出席董事 7 人，出席和授权出席董事 7 人。 二、议案审议情况 （一）审议通过《关于向招商银行股份有限公司合肥分行申请 3000 万元人 民币最高授信额度的议案》 1.议案内容： 根据公司业务发展以及经营管理的需要，同 ...

证券代码：835892 证券简称：中科美菱 公告编号：2025-105 中科美菱低温科技股份有限公司 董事会战略委员会议事规则 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、审议及表决情况 2025 年 9 月 17 日，公司召开第四届董事会第四次会议，审议通过了《关 于制定及修订公司部分内部管理制度的议案》之子议案 2.26《关于修订<董事 会战略委员会议事规则>的议案》，议案表决结果：同意 7 票，反对 0 票，弃权 0 票。此议案无需提交股东会审议。 二、分章节列示制度主要内容： 第一章 总则 第一条 为进一步完善公司治理结构，健全决策程序，加强决策科学性， 提高重大决策的质量，根据《中华人民共和国公司法》《中华人民共和国证券 法》《上市公司治理准则》《中科美菱低温科技股份有限公司章程》（以下简称 《公司章程》）及其他有关规定，公司董事会设立战略委员会，制定本议事规 则。 第二条 董事会战略委员会是董事会的专门工作机构，主要负责对公司长 期发展战略和重大投资决策进行研究并提出决策建议。 第二 ...